March 14 (Reuters) - Third Wave Technologies Inc (TWTI.O: Quote, Profile, Research) said the U.S. Food and Drug Administration cleared the diagnostics company’s test, called InPlex CF Molecular Test, that detects and identifies cystic fibrosis mutations in DNA samples.
